Seres Therapeutics
MCRB
MCRB
131 hedge funds and large institutions have $535M invested in Seres Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 45 increasing their positions, 54 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 54
17% less capital invested
Capital invested by funds: $642M → $535M (-$108M)
70% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 23
Holders
131
Holding in Top 10
1
Calls
$3.16M
Puts
$1.99M
Top Buyers
| 1 | +$7.81M | |
| 2 | +$5.35M | |
| 3 | +$3.33M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.78M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.57M |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$4.34M | |
| 3 | -$3.14M | |
| 4 |
HF
HRT Financial
New York
|
-$2.61M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.49M |